Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis

Gastroenterology(2020)10.1053/j.gastro.2020.06.043Source: DataRank Database

Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis is a research paper published in Gastroenterology (2020). On theSindex it has a DataRank of 0. It has been cited 212 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access212 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 7.26)OA: greenTopics (102)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sushrut Jangi ORCID,Parambir S. Dulai ORCID,Brigid S. Boland ORCID,Larry J. Prokop ORCID,Vipul Jairath ORCID

Live enrichment

PubMed:32585306 PMC:PMC7658293 OpenAlex:https://openalex.org/W3036896286

Crohn's and Colitis Foundation

Grant: 404614

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: K23-DK-117058

American College of Gastroenterology

Grant: 144271

NIDDK NIH HHS

Grant: P30 DK120515

NIDDK NIH HHS

Grant: K23 DK123406

NIDDK NIH HHS

Grant: K23 DK117058

National Institutes of Health

Grant: 5K23DK117058-05

Comparative Risks and Benefits of Pharmacological Therapies for Older Patients with Inflammatory Bowel Diseases

National Institutes of Health

Grant: 5P30DK120515-04

San Diego Digestive Diseases Research Center

National Institutes of Health

FWCI

7.26

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7658293

publisherhttps://api.elsevier.com/content/article/PII:S0016508520348447?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508520348447?httpAccept=text/plain

journalhttps://doi.org/10.1053/j.gastro.2020.06.043

Fields of Study

Inflammatory Bowel DiseaseMicroscopic ColitisLiver Diseases and Immunity0302 clinical medicine03 medical and health sciences

MeSH Terms

AdolescentAdultAgedBiopsyColitis, UlcerativeColonColonoscopyFemaleGastrointestinal AgentsHumansMaleMiddle AgedPredictive Value of TestsRecurrenceRemission InductionRisk FactorsTime FactorsTreatment OutcomeRisk AssessmentYoung Adult

Keywords

Meta-analysisUlcerative colitisMedicineInternal medicineGastroenterologySystematic reviewMEDLINEDiseaseInflammationBiopsyAbdominal PainInflammatory Bowel DiseaseIbdTreat-to-targetMaleUlcerative (mesh)Colonoscopy (mesh)Time FactorsUlcerativeGastrointestinal Agents (mesh)RecurrenceRisk Factors1103 Clinical Sciences (for)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Remission Induction (mesh)Humans (mesh)Time Factors (mesh)Young Adult (mesh)Colon (mesh)Treatment Outcome (mesh)Remission InductionColonoscopyMiddle AgedColitisTreatment Outcome6.1 PharmaceuticalsRisk Assessment (mesh)FemaleRecurrence (mesh)Digestive Diseases (rcdc)AdultPredictive Value of Tests (mesh)AdolescentColonClinical Sciences610Autoimmune DiseaseRisk Assessment1114 Paediatrics and Reproductive Medicine (for)Paediatrics and Reproductive Medicine3210 Nutrition and dietetics (for-2020)Young AdultGastrointestinal AgentsRisk Factors (mesh)Predictive Value of TestsInflammatory Bowel Disease (rcdc)616Middle Aged (mesh)Humans3202 Clinical Sciences (for-2020)AgedAutoimmune Disease (rcdc)6.1 Pharmaceuticals (hrcs-rac)Biomedical and Clinical SciencesGastroenterology & HepatologyAged (mesh)NeurosciencesAdolescent (mesh)1109 Neurosciences (for)Biopsy (mesh)Nutrition and dieteticsFemale (mesh)Adult (mesh)Colitis, UlcerativeGastroenterology & Hepatology (science-metrix)Digestive Diseases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being